Beijing, China

Xianmei Qi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences, Cams. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianmei Qi. Retrieved from https://idiyas.com/inventor/xianmei-qi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xianmei Qi: Innovator in Medical Science

Introduction

Xianmei Qi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the development of treatments for pulmonary conditions. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Xianmei Qi's latest patents include innovative approaches to treating serious health issues. One of his notable patents is the "Use of FcgammaRIII Inhibitor in Preparation of Medicament for Treating Pulmonary Fibrosis." Another significant patent is the "Use of Malic Enzyme 1 (ME1) in Preparation of Drug for Preventing and Treating Pulmonary Hypertension (PH)." These inventions reflect his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Xianmei Qi has worked with esteemed institutions such as the Institute of Basic Medical Sciences and the Chinese Academy of Medical Sciences. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Xianmei Qi has collaborated with notable colleagues, including Jing Wang and Ya Luo. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Xianmei Qi's innovative work in medical science demonstrates his dedication to improving health outcomes through research and invention. His patents and collaborations highlight his significant role in advancing treatments for pulmonary diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…